Substance Abuse & Addiction
Search All News
Smithers Center at Columbia University Irving Medical Center provides evidence-based care to individuals seeking treatment for substance use disorders and co-occurring mental health conditions.
In a Phase 2a clinical trial, Columbia researchers found that the drug AEFO117 significantly reduced the effects of cannabis in daily cannabis smokers.
A Columbia study finds that adolescents who use cannabis recreationally are two to four times as likely to develop psychiatric disorders then teens who don’t use cannabis at all.
- December 5, 2019
Researchers findings at Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute could lead to a new approach to the treatment of alcohol use disorder.
Source:Philly VoiceDecember 5, 2019
"In our participants, ketamine appears to have increased resilience and reduced demoralization after a lapse," Dr. Elias Dakwar said.
Source:FilterDecember 5, 2019
Dr. Elias Dakwar has conducted laboratory and clinical investigations of ketamine infusion and mindfulness training to treat cocaine use disorder.
Source:MedscapeDecember 3, 2019
"The rate at which individuals relapsed and overdosed after ending treatment was alarmingly high, suggesting that discontinuing buprenorphine is a life-threatening event," said Dr. Williams.
- December 2, 2019
People with opioid addiction face a high risk of overdose after ending treatment, even when treated for 18 months, a Columbia study has found.
- September 10, 2019
Dr. Katherine Elkington, Associate Professor of Clinical Psychology (in Psychiatry) at Columbia University, discusses the complex connection between suicide and substance use in adolescents.
Source:MD MagazineJune 26, 2019
Dr. Elias Dakwar sought proof of the suggestion that concentrated doses of ketamine may help reduce vulnerabilities associated with cocaine use, and improve the likelihood of relapse prevention.
- January 25, 2019
Researchers at Columbia have developed a “Cascade of Care” model for treating individuals with opioid use disorder based on lessons learned in the HIV/AIDS field.